Invivyd (IVVD) Revenue (2024 - 2025)
Invivyd (IVVD) reported Revenue of $17.2 million for Q4 2025, up 24.51% on a YoY basis from $13.8 million in Q4 2024, and up 31.06% quarter-over-quarter from $13.1 million in Q3 2025.
Invivyd (IVVD) Revenue (2024 - 2025) Analysis & Trends
Invivyd has reported Revenue for 2 years, with the latest figure at $17.2 million in Q4 2025.
- For the quarter ending Q4 2025, Revenue rose 24.51% year-over-year to $17.2 million; the trailing twelve-month figure through Dec 2025 stood at $53.4 million (up 110.47% YoY), and the FY2025 full-year result was $53.4 million, up 110.47% from the prior year.
- Revenue for Q4 2025 stood at $17.2 million, up from $13.1 million in the prior quarter.
- The five-year high for Revenue was $17.2 million in Q4 2025, with the low at $2.3 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 17.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.21 Mn |
| Sep 30, 2025 | 13.13 Mn |
| Jun 30, 2025 | 11.79 Mn |
| Mar 31, 2025 | 11.30 Mn |
| Dec 31, 2024 | 13.82 Mn |
| Sep 30, 2024 | 9.30 Mn |
| Jun 30, 2024 | 2.26 Mn |